Department of Biomedical Sciences and Human Oncology, Laboratory of Medical Genetics, Università di Bari Aldo Moro, Bari, Italy.
Rare Disease Center, Internal MedicineUnit 'C. Frugoni', AOU Policlinico di Bari, Bari, Italy.
Hum Mutat. 2022 Oct;43(10):1354-1360. doi: 10.1002/humu.24423. Epub 2022 Jun 28.
Neurofibromatosis type 1 (NF1) belongs to RASopathies, a group of syndromes caused by germline mutations in Ras/MAPK pathway genes. Most NF1 patients exhibit single inactivating pathogenic variants within the NF1 gene. We performed extensive genetic analyses in two NF1 families disclosing the first two cases of double de novo monoallelic NF1 variants. Both index patients described in this study had classical NF1. Probands were born from fathers in their late 30s and presented closely spaced double mutations (<100 bp) in NF1 regions showing an excess of somatic mutations. Closely spaced multiple mutations have been reported in RAS/MAPK signaling genes but never in NF1. Mutagenesis is a quasi-random process in humans, therefore two causative variants in the same gene, moreover in the same allele are exceptional. Here, we discuss possible mechanisms for this ultrarare event. Our findings confirm the possibility of a higher risk of concurrent de novo variants in NF1.
神经纤维瘤病 1 型(NF1)属于 Ras 通路病(RASopathies),这是一组由 Ras/MAPK 通路基因突变引起的综合征。大多数 NF1 患者在 NF1 基因中存在单个失活的致病性变异。我们对两个 NF1 家系进行了广泛的遗传分析,揭示了首例双从头单等位基因 NF1 变异的两例病例。本研究中描述的两名先证者均患有典型的 NF1。患儿的父亲均在 30 多岁时生育,NF1 区域存在紧密间隔的双突变(<100bp),体细胞突变过多。RAS/MAPK 信号转导基因中已报道了紧密间隔的多个突变,但从未在 NF1 中报道过。在人类中,突变是一种准随机过程,因此在同一个基因中,甚至在同一个等位基因中出现两个致病变异是异常的。在这里,我们讨论了这种超罕见事件的可能机制。我们的发现证实了 NF1 中同时发生从头变异的风险可能更高。